MARCIA O'BRIEN: Open Payments
NPI 1053853176 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$738 in 24 payments from 15 companies in 2025. Trend: 2023 $746 · 2024 $495 · 2025 $738
Food & beverage: $738
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 2 | $122 |
| Novo Nordisk Inc | 1 | $109 |
| UROGEN PHARMA, INC. | 3 | $65 |
| Endo USA, Inc. | 2 | $59 |
| Procept Biorobotics Corporation | 2 | $57 |
| PFIZER INC. | 3 | $56 |
| 180 Medical, Inc. | 1 | $48 |
| Teleflex LLC | 2 | $47 |
| ABBVIE INC. | 2 | $47 |
| PROGENICS PHARMACEUTICALS, INC. | 1 | $24 |
Products named: Ozempic, RYBREVANT, AVEED, AQUABEAM ROBOTIC SYSTEM, XTANDI, BOTOX, JELMYTO, UROLIFT.
Industry payments across TX — which companies pay providers there.
